Quipt Home Medical (TSE:QIPT – Get Free Report) had its price objective lowered by equities research analysts at Stifel Nicolaus from C$8.40 to C$7.50 in a research note issued on Thursday,BayStreet.CA reports. The firm currently has a “buy” rating on the stock. Stifel Nicolaus’ price target would indicate a potential upside of 110.67% from the company’s previous close.
Quipt Home Medical Stock Performance
Shares of TSE QIPT opened at C$3.56 on Thursday. The stock has a fifty day simple moving average of C$3.72 and a 200-day simple moving average of C$4.14. Quipt Home Medical has a twelve month low of C$3.28 and a twelve month high of C$6.98. The stock has a market capitalization of C$153.40 million, a PE ratio of -20.94 and a beta of 1.01.
Quipt Home Medical Company Profile
Featured Articles
- Five stocks we like better than Quipt Home Medical
- 3 Best Fintech Stocks for a Portfolio Boost
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- How to Calculate Options Profits
- 3 Penny Stocks Ready to Break Out in 2025
- What Are Dividends? Buy the Best Dividend Stocks
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.